Histaminergic regulation of NK-cells: Protection against monocyte-induced apoptosis

被引:23
作者
Hansson, M [1 ]
Asea, A [1 ]
Hermodsson, S [1 ]
Hellstrand, K [1 ]
机构
[1] GOTHENBURG UNIV,DEPT VIROL,S-41346 GOTHENBURG,SWEDEN
关键词
D O I
10.1046/j.1365-3083.1996.d01-291.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Human natural killer (NK) cells with CD3(-)/56(+) phenotype) acquired features characteristic of apoptosis after incubation with autologous monocytes, as revealed by apoptotic nuclear morphology and degradation of DNA into oligonucleosomal fragments. The monocyte-induced apoptosis in NK-cells was prevented by the biogenic amine histamine at concentrations exceeding 0.1 mu M. The protective effect of histamine was blocked by the H-2-receptor (H(2)R) antagonist ranitidine but not by AH202399 A, a chemical control to ranitidine devoid of H(2)R affinity. It is concluded that histaminergic mechanisms may serve to protect NK cells from damage inflicted by products of the oxidative metabolism of monocytes.
引用
收藏
页码:193 / 196
页数:4
相关论文
共 14 条
[1]   Histaminergic regulation of natural killer cell-mediated clearance of tumour cells in mice [J].
Asea, A ;
Hermodsson, S ;
Hellstrand, K .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1996, 43 (01) :9-15
[2]  
BEER DJ, 1987, CRC CR REV IMMUNOL, V7, P55
[3]   Remission maintenance therapy with histamine and interleukin-2 in acute myelogenous leukaemia [J].
Brune, M ;
Hellstrand, K .
BRITISH JOURNAL OF HAEMATOLOGY, 1996, 92 (03) :620-626
[4]  
COHEN JJ, 1993, IMMUNOL TODAY, V14, P126, DOI 10.1016/0167-5699(93)90214-6
[5]  
HANSSON M, 1996, J IMMUNOL, V156, P1
[6]   CELL-TO-CELL MEDIATED INHIBITION OF NATURAL-KILLER-CELL PROLIFERATION BY MONOCYTES AND ITS REGULATION BY HISTAMINE H-2-RECEPTORS [J].
HELLSTRAND, K ;
HERMODSSON, S .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1991, 34 (06) :741-752
[7]  
HELLSTRAND K, 1986, J IMMUNOL, V137, P656
[8]   HISTAMINE IN IMMUNOTHERAPY OF ADVANCED MELANOMA - A PILOT-STUDY [J].
HELLSTRAND, K ;
NAREDI, P ;
LINDNER, P ;
LUNDHOLM, K ;
RUDENSTAM, CM ;
HERMODSSON, S ;
ASZTELY, M ;
HAFSTROM, L .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 1994, 39 (06) :416-419
[9]   SYNERGISTIC ACTIVATION OF HUMAN NATURAL-KILLER-CELL CYTOTOXICITY BY HISTAMINE AND INTERLEUKIN-2 [J].
HELLSTRAND, K ;
HERMODSSON, S .
INTERNATIONAL ARCHIVES OF ALLERGY AND APPLIED IMMUNOLOGY, 1990, 92 (04) :379-389
[10]  
HELLSTRAND K, 1990, J IMMUNOL, V145, P4365